Status:
RECRUITING
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
Lead Sponsor:
National Cancer Center, Korea
Conditions:
CNS Germinoma
CNS Tumor
Eligibility:
All Genders
Brief Summary
\<Purpose of the Research\> * Primary Establishing an Asian consortium to establish a database of pediatric CNS tumors in the prospective manner The target disease of this research focuses on pediatr...
Detailed Description
\<Selection standards\> * A patient who was diagnosed with CNS GCT and agreed to participate in the research between 2022-2027. * Patients diagnosed between 2016-2022 can be enrolled if the partic...
Eligibility Criteria
Inclusion
- A patient who was diagnosed with CNS GCT and agreed to participate in the research between 2022-2027.
- Patients diagnosed between 2016-2022 can be enrolled if the participating institute has IRB approval for recruiting these patients as separate IRB document (Seoul Asan Hospital) or by comprehensive IRB document (Singapore NCC, Taiwan Medical University), or by recruitment on the basis of acquirement of the consent form for research (NCC, Korea).
- The age at the time of diagnosis is 0\< ≤40 years
- A patent who has been diagnosed with the relevant tumor via an operation or a biopsy ⑤ In the case of CNS germinoma, a biopsy may not have been performed on a patient. In this case, the patient may register as germinoma if he or she meets the following criteria: -Germinoma is strongly suspected radiologically, and a tumor marker from serum or cerebrospinal fluid (CSF) has not increased above the institute's reference normal value; -Germinoma is suspected radiologically, and a tumor marker from serum or CSF has elevated above the institute's reference normal value (tumor markers may be AFP or hCG)
Exclusion
- ① The patient or the guardian of the patient did not consent to participate.
Key Trial Info
Start Date :
August 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05982691
Start Date
August 5 2022
End Date
December 31 2032
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center, Korea
Goyang-si, Gyeonggi-do, South Korea, 410-769